Pilot of non-invasive (oral fluid) testing for HIV within a clinical setting

Sexual Health

Volumn 4, Issue 2, 2007, Pages 105-109

  Debattista, Joseph ^a   Bryson, Gregory ^b   Roudenko, Nicole ^b   Dwyer, John ^a   Kelly, Mark ^a   Hogan, Patrick ^b   Patten, John ^a  

^a Northside Health Service District   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

AMBULATORY CARE; ARTICLE; BIOASSAY; BLOOD ANALYSIS; BODY FLUID; CONTROLLED STUDY; DIAGNOSTIC KIT; FALSE POSITIVE RESULT; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INVASIVE MEASUREMENT; OUTPATIENT; PATIENT ATTITUDE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE; VIRUS DETECTION;

AIDS SERODIAGNOSIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; PILOT PROJECTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 34249286994     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH07014     Document Type: Article

References (21)

1. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001; 91: 1019-24.
2. Hilton C, Sabundayo B, Langan S, Hilton M, Henson C, Quinn T, et al. Screening for HIV infection in high risk communities by urine antibody testing. J Acquir Immune Defic Syndr 2002; 31: 416-21.
3. Vajdic CM, Middleton M, Bowden FJ, Fairley CK, Kaldor JM. The prevalence of genital Chlamydia trachomatis in Australia 1997-2004: a systematic review. Sex Health 2005; 2: 169-83. doi: 10.1071/SH05018
4. Mylonakis E, Paliou M, Lally M, Flanigan T, Rich J. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med 2000; 109: 568-76. doi: 10.1016/S0002-9343(00)00583- 0
5. Gallo D, George JR, Fitchen JH, Goldstein AS, Hindahl MS. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group. JAMA 1997; 277: 254-8. doi: 10.1001/jama.277.3.254
6. Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med 1997; 102: 9-14. doi: 10.1016/S0002-9343(97)00032-6
7. Exner TM, Ehrhardt AA, Loeb I, Zawadzki R. HIV counselling and testing: women's experiences and the role of testing as a prevention strategy. XI International Conference on AIDS, Vancouver July 1996. Abstract # WeC. 3529. Vancouver, B.C.: XI International Conference on AIDS Society.
8. Meehan M, Sewankambo N, Wawer M, McNairn D, Quinn T, Lutalo T, et al. Sensitivity and specificity of HIV testing of urine compared with sperum specimens: Rakai Uganda. Sex Transm Dis 1999; 26: 590-2. doi: 10.1097/00007435-199911000-00009
9. Dodds JP, Mercey DE, Parry JV, Johnson AM. Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect 2004; 80: 236-40. doi: 10.1136/sti.2003.007286
10. Vargo S, Agronick G, O'Donnell L, Stueve A. Using peer recruitment and OraSure to increase HIV testing. Am J Public Health 2004; 94: 29-31.
11. Osmond DH, Catania J, Pollack L, Canchola J, Jaffe D, MacKellar D, et al. Obtaining HIV test results with a home collection test kit in a community telephone sample. J Acquir Immune Defic Syndr 2000; 24: 363-8.
12. Sy FS, Rhodes SD, Choi ST, Drociuk D, Laurent AA, Naccash RM, et al. The acceptability of oral fluid testing for HIV antibodies. A pilot study in gay bars in a predominantly rural state. Sex Transm Dis 1998; 25: 211-5. doi: 10.1097/00007435-199804000-00006
13. Granade TC, Phillips SK, Parekh B, Gomez P, Kitson-Piggott W, Oleander H, et al. Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance. Clin Diagn Lab Immunol 1998; 5: 171-5.
14. Emmons W. Accuracy of oral specimen testing for human immunodeficiency virus. Am J Med 1997; 102: 15-20. doi: 10.1016/S0002-9343(97)00033-8
15. Pugatch D, Levesque B, Greene S, Strong L, Flanigan T, Lally M. HIV testing in the setting of inpatient acute substance abuse treatment. Am J Drug Alcohol Abuse 2001; 27: 491-9. doi: 10.1081/ADA-100104514
16. Pugatch DL, Levesque BG, Lally MA, Reinert SE, Filippone WJ, Combs CM, et al. HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment. J Acquir Immune Defic Syndr 2001; 27: 135-42.
17. Clair S, Singer M, Huertas E, Weeks M. Unintended consequences of using an oral HIV test on HIV knowledge. AIDS Care 2003; 15: 575-80. doi: 10.1080/0954012031000134809
18. Summers T, Spielberg F, Collins C, Coates T. Voluntary counselling, testing and referral for HIV: new technologies, research findings create dynamic opportunities. J Acquir Immune Defic Syndr 2000; 25: S128-35. doi: 10.1097/00042560-200012152-00007
19. George JR, Fitchen JH. Future applications of oral fluid specimen technology. Am J Med 1997; 102: 21-5. doi: 10.1016/S0002-9343(97)00034-X
20. Judd A, Parry J, Hickman M, McDonald T, Jordan L, Lewis K, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003; 71: 49-55. doi: 10.1002/jmv.10463
21. Judd A, Hutchinson S, Wadd S, Hickman M, Taylor A, Jone S, et al. Prevalence of, and risk factors for hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. J Viral Hepat 2005; 12: 655-62. doi: 10.1111/j.1365-2893.2005.00643.x